EUVIMEDEUVIMED entdecken
Crossref

Immunological implications of the use of tyrosine kinase inhibitors in chronic myeloid leukemia

Camila De Souza Rodrigues, Larine Miranda Mendonça, Jhony Robison de Oliveira, Marcelo Henrique Napimoga, Maria Theresa Cerávolo Laguna Abreu

Journal of Hematological Malignancies · 2012

DOI: 10.5430/jhm.v2n3p45 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Hematological Malignancies, 2012. Verfasst von Camila De Souza Rodrigues und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Rodrigues, C. D. S., Mendonça, L. M., Oliveira, J. R. D., Napimoga, M. H., & Abreu, M. T. C. L. (2012). Immunological implications of the use of tyrosine kinase inhibitors in chronic myeloid leukemia. Journal of Hematological Malignancies. https://doi.org/10.5430/jhm.v2n3p45

Vancouver

Rodrigues CDS, Mendonça LM, Oliveira JRD, Napimoga MH, Abreu MTCL. Immunological implications of the use of tyrosine kinase inhibitors in chronic myeloid leukemia. Journal of Hematological Malignancies. 2012. doi:10.5430/jhm.v2n3p45

BibTeX
@article{Rodrigues2012,
  author = {Rodrigues, Camila De Souza and Mendonça, Larine Miranda and Oliveira, Jhony Robison de and Napimoga, Marcelo Henrique and Abreu, Maria Theresa Cerávolo Laguna},
  title = {Immunological implications of the use of tyrosine kinase inhibitors in chronic myeloid leukemia},
  journal = {Journal of Hematological Malignancies},
  year = {2012},
  doi = {10.5430/jhm.v2n3p45}
}
Kostenlos starten →